Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Aravive, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ARAV: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders303−27
Shares6.70M1.88M−4.82M (−72.0%)
Value$825.5K$69.4K−$756.2K (−91.6%)

New holders (1)

Institutions that held Aravive, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ARAV in Q1 2024
InstitutionSharesValue% of portfolio
XTX Topco Ltd108,440$00.00%

Sold out (28)

Institutions that held Aravive, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.